This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Chuangyu Lin: Innovator in Sulfonamide Pharmaceutical Composition
Introduction
Chuangyu Lin is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on sulfonamide compounds. His expertise and dedication to research have led to the development of a unique injectable preparation that enhances the effectiveness of sulfonamide treatments.
Latest Patents
Chuangyu Lin holds a patent for a sulfonamide pharmaceutical composition. This invention relates to a sulfonamide compound injectable preparation that includes a sulfonamide compound or its derivative. The preparation is created using a pharmaceutically acceptable carrier and specific preparation technologies. The resulting injectable preparation is noted for its stability, quality control, and effectiveness in medical applications. He has 1 patent to his name.
Career Highlights
Chuangyu Lin is associated with Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd. His role in the company has allowed him to focus on the development of innovative medical technologies. His work has been instrumental in advancing pharmaceutical formulations that improve patient outcomes.
Collaborations
Chuangyu Lin has collaborated with several professionals in his field, including Li Tian and Yi Juang Wu. These collaborations have fostered a productive environment for innovation and research in pharmaceutical technology.
Conclusion
Chuangyu Lin's contributions to the field of pharmaceuticals, particularly through his sulfonamide pharmaceutical composition, highlight his role as an innovator. His work continues to impact the medical community positively, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile